Table 1: Summary of laboratory results from previously reported cases and current case.

 

Patient

Age

Anti-PD-1 Agent

Glucose Level at Presentation

C-peptide Level

GAD65 antibody positive?

1

54 F

Pembrolizumab

N/A

N/A

No

2

55 F

Nivolumab

532 mg/dL

< 0.1 ng/mL

Yes

3

58 M

Nivolumab

749 mg/dL

< 0.1 ng/mL

Yes

4

63 M

Nivolumab

247 mg/dL

1.3 ng/mL

Yes

5

64 M

Pembrolizumab

703 mg/dL

0.5 ng/mL

No

6*

77 F

Nivolumab

504 mg/dL

0.81 ng/mL

No

7

83 F

Nivolumab

350 mg/dL

< 0.1 ng/mL

Yes

 

*Patient 6 represents data obtained from the case reported in this manuscript.